Dicot has contracted Thermo Fisher Scientific for manufacturing of LIB-01
Press release: Uppsala, January 19, 2023. The pharmaceutical company Dicot has contracted Thermo Fisher Scientific, the world leader in serving science, to perform GMP manufacturing of the drug candidate LIB-01 for the upcoming clinical trials.Dicot is developing a new potency drug with the aim to treat erectile dysfunction and premature ejaculation better than existing drugs. The company has previously announced its intention to start clinical studies with the drug candidate LIB-01 in mid-2023. For GMP (Good Manufacturing Practice) manufacturing of study drug to be used in the phase 1